Seer, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Seer, Inc. on October 4, 2024. The filing discloses a corporate action regarding the repricing of underwater stock options approved by the Board of Directors on the same date.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to equity compensation adjustments:
- Stock Price: $2.00 per share (closing price on October 4, 2024).
- Repriced Options: Approximately 7.9 million shares underlying eligible options.
- New Exercise Price: $2.00 per share for repriced options.
- Original Exercise Prices: Ranged from $2.08 to $60.15 per share.
Material Changes
The Board approved a repricing of nonstatutory stock options held by continuing employees that were "underwater" (exercise price greater than $2.00). Key changes include:
- Option Repricing: Eligible options granted under the 2017 and 2020 Equity Incentive Plans with exercise prices above $2.00 were adjusted to a new exercise price of $2.00.
- Retention Period Penalty: If an employee exercises a repriced option before the end of the Retention Period (ending April 4, 2026, or upon Change in Control/Death/Disability), they must pay the original, higher exercise price.
- Performance Award Amendments: Certain 2023 performance-based options with stock price hurdles were amended. The hurdle was adjusted to 150% of $2.00 (up from the original $6.89).
- Executive Impact: The repricing applies to CEO Omid Farokhzad (2,732,470 shares) and President/CFO David Horn (1,140,454 shares).
- Future Grants: The Board determined not to make additional equity awards in 2025 to executive officers with the title of Senior Vice President and higher.
Guidance, Outlook, and Risks
The filing contains no financial guidance or outlook. Management commentary indicates the repricing was designed to retain and motivate employees without incurring significant additional equity dilution or cash expenditures. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ due to risks detailed in the Company's Form 10-K and 10-Q filings.
Investor Verification Checklist
- Verify the total number of shares subject to repricing (approx. 7.9 million) against the company's total outstanding share count to assess dilution impact.
- Review the specific terms of the "Retention Period" to understand the conditions under which the premium exercise price applies.
- Confirm the impact of the repricing on the company's stock-based compensation expense in future quarters.
- Check subsequent filings for any changes to the 2025 equity grant policy for senior executives.